Search research articles
Contact Us
Filters
Showing results (31-40 of 202) with videos related to
Page
of 21
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2013
Which health-related quality-of-life outcome when planning randomized trials: disease-specific or generic, or both? A common factor model
A E Ades, Guobing Lu, Jason J Madan
Archives of Disease in Childhood
|
March 1, 1991
Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria
I Smith, M G Beasley, A E Ades
Statistics in Medicine
|
October 22, 2010
Parameterization of treatment effects for meta-analysis in multi-state Markov models
Malcolm J Price, Nicky J Welton, A E Ades
Journal of Clinical Epidemiology
|
August 7, 2010
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti, A E Ades, John P A Ioannidis
Journal of Clinical Epidemiology
|
January 19, 2010
Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency
Deborah M Caldwell, Nicky J Welton, A E Ades
Journal of Clinical Pathology
|
May 1, 1992
Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii
W D Cubitt, A E Ades, C S Peckham
Journal of Clinical Pathology
|
September 1, 1992
Plasma total thyroxine and free thyroxine concentrations in congenital hypothyroidism before and during treatment
S L Tillotson, D B Grant, A E Ades
Pharmacoeconomics
|
September 5, 2008
Use of indirect and mixed treatment comparisons for technology assessment
Alex Sutton, A E Ades, Nicola Cooper, et al.
Archives of Disease in Childhood
|
May 23, 2001
Coverage of neonatal screening: failure of coverage or failure of information system
A E Ades, J Walker, R Jones, et al.
Research Synthesis Methods
|
June 11, 2015
Synthesis of survival and disease progression outcomes for health technology assessment of cancer therapies
N J Welton, S R Willis, A E Ades
Page
of 21
Search research articles
Search
Showing results (31-40 of 202) with videos related to
Sort By:
Page
of 21
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2013
Which health-related quality-of-life outcome when planning randomized trials: disease-specific or generic, or both? A common factor model
A E Ades, Guobing Lu, Jason J Madan
Archives of Disease in Childhood
|
March 1, 1991
Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria
I Smith, M G Beasley, A E Ades
Statistics in Medicine
|
October 22, 2010
Parameterization of treatment effects for meta-analysis in multi-state Markov models
Malcolm J Price, Nicky J Welton, A E Ades
Journal of Clinical Epidemiology
|
August 7, 2010
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti, A E Ades, John P A Ioannidis
Journal of Clinical Epidemiology
|
January 19, 2010
Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency
Deborah M Caldwell, Nicky J Welton, A E Ades
Journal of Clinical Pathology
|
May 1, 1992
Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii
W D Cubitt, A E Ades, C S Peckham
Journal of Clinical Pathology
|
September 1, 1992
Plasma total thyroxine and free thyroxine concentrations in congenital hypothyroidism before and during treatment
S L Tillotson, D B Grant, A E Ades
Pharmacoeconomics
|
September 5, 2008
Use of indirect and mixed treatment comparisons for technology assessment
Alex Sutton, A E Ades, Nicola Cooper, et al.
Archives of Disease in Childhood
|
May 23, 2001
Coverage of neonatal screening: failure of coverage or failure of information system
A E Ades, J Walker, R Jones, et al.
Research Synthesis Methods
|
June 11, 2015
Synthesis of survival and disease progression outcomes for health technology assessment of cancer therapies
N J Welton, S R Willis, A E Ades
Page
of 21